Description
What is Tirzepatide?
Tirzepatide, known by its brand name Mounjaro, is a newer weight loss injection that targets two receptors: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). This dual-action mechanism not only aids in weight loss but also improves blood sugar control, making it a versatile option for those struggling with obesity and type 2 diabetes. Tirzepatide’s dual receptor approach offers enhanced benefits over single-action treatments.
- ⋙ Targets both GLP-1 and GIP receptors.
- ⋙ Promotes significant weight loss and blood sugar control.
- ⋙ Once-weekly injection for ease of use.
- ⋙ Suitable for patients with type 2 diabetes.




